Evidence map›Paper›PMID 39888654›Full record

ArticleVascular biology (Bristol, England)2025

Serum tissue plasminogen activator after cycling with blood flow restriction.

Josh B Landers, Melissa Allen, Ibrahim Oladele, Leah Lowe, Nawab Ali, Jacquie Rainey, James Fletcher, Korben Landers

Abstract read
In one paragraph

Article in Vascular biology (Bristol, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josh B LandersLyon College Institute of Health Sciences, Lyon College of Dental Medicine, Little Rock, Arkansas, USA.ORCID https://orcid.org/0009-0004-4887-6658
Melissa AllenUCA Department of Physical Therapy, Conway, Arkansas, USA.
Ibrahim OladeleCenter for Integrative Nanotechnology Sciences, University of Arkansas at Little Rock, Little Rock, Arkansas, USA.
Leah LoweUCA Department of Physical Therapy, Conway, Arkansas, USA.
Nawab AliDepartment of Biology, University of Arkansas at Little Rock, Little Rock, Arkansas, USA.
Jacquie RaineyDepartment of Health Sciences, Conway, Arkansas, USA.
James FletcherUCA Department of Physical Therapy, Conway, Arkansas, USA.
Korben LandersPsychology Department, University of Arkansas at Little Rock, Little Rock, Arkansas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood flow restriction exercise (BFRE) is a therapeutic approach traditionally used to facilitate muscular strength and hypertrophy. Emerging evidence has identified its benefits on other systems and metabolic processes. The emphasis of this study was to examine potential impact of BFRE on serum levels of tissue plasminogen activator (tPA). Eighteen healthy adults (nine males, nine females; mean age: 34.44 ± 9.97) were randomized into groups to perform cycling either with or without blood flow restriction (BFR). Blood samples were collected before and after exercise to analyze serum concentrations of tPA. Significance in tPA between exercise groups did not reach significance but did show a large effect size (0.14) in favor of the BFR group. The trend suggests that this study was underpowered to reach significance. Further research should continue examining the impact of BFRE on serum levels of tPA. This methodology could be adapted to other populations to increase generalizability of results.

Indexed as

blood flow restriction exercisetissue plasminogen activatorvascular occlusion training

Identifiers

PMID39888654
PMCPMC11850040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.